StonvexLoading…
StonvexStonvexStonvexCore line items from NEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.31B | $22.67B | $15.85B | $10.33B |
Operating Income | $4.58B | $11.34B | $8.10B | $5.59B |
Net Income | $3.26B | $7.08B | $5.78B | $3.95B |
EPS (Diluted) | $3.00 | $6.39 | $5.20 | $3.53 |
Total Assets | $57.67B | $57.12B | $54.69B | $55.16B |
Total Liabilities | $22.57B | $23.08B | $21.28B | $22.88B |
Cash & Equivalents | $8.78B | $7.65B | $5.64B | $6.18B |
Free Cash Flow OCF − CapEx | $3.14B | $7.30B | $4.49B | $2.92B |
Shares Outstanding | 1.09B | 1.09B | 1.11B | 1.12B |